Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 532天前

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 688天前

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 804天前

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 1178天前

Indian Shares Follow Global Peers Lower

Indian shares opened lower on Friday, mirroring weak cues from global markets as uncertainty persists over Federal Reserve interest-rate cuts and stretched valuations in technology stocks.

RTTNews | 1小时11分钟前

Australian Market Maintains Early Sharp Losses In Mid-market

The Australian stock market is maintaining its early sharp losses in mid-market moves on Friday, extending the losses in the previous three sessions, following the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling well below the 8,650 level, with weakness across all sectors led by mining and technology stocks.

RTTNews | 2小时28分钟前

Asian Markets Track Wall Street Lower

Asian stock markets are trading mostly lower on Friday, following the broadly negative cues from Wall Street overnight, reflecting uncertainty whether key U.S. economic reports will be released following the end of the longest government shutdown in U.S. history, which could alter the US Fed's decision on interest rates. Asian markets ended mostly higher on Thursday.

RTTNews | 2小时50分钟前

Indian Shares Set For Muted Opening; Bihar Election Results Eyed

Indian shares are set for a muted opening on Friday as investors await the Bihar election results for directional cues.

RTTNews | 3小时8分钟前

EURUSD	1.16397	GBPUSD	1.3141	AUDUSD	0.65334
USDJPY	154.496	USDCAD	1.40292	USDCHF	0.79216